What Researchers Did
This systematic review examined randomized controlled trials to determine the effectiveness and safety of hyperbaric oxygen therapy (HBOT) as an additional treatment for acute ischaemic stroke.
What They Found
Researchers identified three randomized controlled trials involving 106 participants that compared HBOT to no HBOT for acute ischaemic stroke. The review found no significant differences in clinically important outcomes between the groups receiving HBOT and those who did not.
What This Means for Canadian Patients
Based on this review, there is currently insufficient evidence to support the use of hyperbaric oxygen therapy as an effective treatment for acute ischaemic stroke in Canadian patients. Individuals experiencing a stroke should continue to receive established, evidence-based medical care.
Canadian Relevance
No direct Canadian connection identified. Acute ischaemic stroke is not a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
The review was limited by the small number of included trials and participants, making it difficult to draw strong conclusions about HBOT for acute ischaemic stroke.